Compare
Cellebrite DI Ltd. vs PagerDuty, Inc. vs Xperi Inc. vs N-able, Inc.
| Latest fiscal year | Cellebrite DI Ltd. CLBT | PagerDuty, Inc. PD | Xperi Inc. XPER | N-able, Inc. NABL |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2026-01-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $475.68M | $492.55M | $448.11M | $508.84M |
| Revenue growth (YoY) | +18.6% | +5.4% | -9.2% | +9.3% |
| Gross margin | 84.2% | 84.9% | n/a | 76.9% |
| Operating margin | 14.0% | 1.2% | -9.8% | 6.7% |
| Net margin | 16.5% | 35.2% | -12.6% | -3.7% |
| Net income | $78.33M | $173.37M | -$56.34M | -$18.82M |
| EPS (Diluted) | $0.31 | $1.87 | -$1.23 | -$0.10 |
| Operating cash flow | $173.54M | $114.86M | -$515.0K | $93.20M |
| Free cash flow | $160.32M | $111.92M | -$5.90M | $75.06M |
| Cash & equivalents | $124.46M | $237.40M | $96.82M | $111.84M |
| Total assets | $938.85M | $990.51M | $615.83M | $1.41B |
| Total liabilities | $454.53M | $719.85M | $201.75M | $607.67M |
| Shareholders' equity | $484.32M | $253.59M | $414.07M | $802.04M |
| Return on year-end equity | 16.2% | 68.4% | -13.6% | -2.3% |
| Shares outstanding | 248.58M | 84.62M | 46.92M | 186.68M |
Revenue, most recent five fiscal years
| Fiscal year | Cellebrite DI Ltd. | PagerDuty, Inc. | Xperi Inc. | N-able, Inc. |
|---|---|---|---|---|
| Latest | $475.68M Ended 2025-12-31 | $492.55M Ended 2026-01-31 | $448.11M Ended 2025-12-31 | $508.84M Ended 2025-12-31 |
| 1 year earlier | $401.20M Ended 2024-12-31 | $467.50M Ended 2025-01-31 | $493.69M Ended 2024-12-31 | $465.55M Ended 2024-12-31 |
| 2 years earlier | $325.11M Ended 2023-12-31 | $430.70M Ended 2024-01-31 | $521.33M Ended 2023-12-31 | $422.16M Ended 2023-12-31 |
| 3 years earlier | $270.65M Ended 2022-12-31 | $370.79M Ended 2023-01-31 | $502.26M Ended 2022-12-31 | $371.77M Ended 2022-12-31 |
| 4 years earlier | $246.25M Ended 2021-12-31 | $281.40M Ended 2022-01-31 | $486.48M Ended 2021-12-31 | $346.46M Ended 2021-12-31 |